These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 12647442

  • 1. [The treatment of schizophrenia--improper choices, adverse events. Preliminary report].
    Marmurowska-Michałowska H, Wysocka A, Dubas-Slemp H, Kozak G.
    Psychiatr Pol; 2002; 36(6 Suppl):217-23. PubMed ID: 12647442
    [Abstract] [Full Text] [Related]

  • 2. Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders. Drug choice, switching and outcome under naturalistic treatment conditions.
    Gaebel W, Riesbeck M, Janssen B, Schneider F, Held T, Mecklenburg H, Sass H.
    Eur Arch Psychiatry Clin Neurosci; 2003 Aug; 253(4):175-84. PubMed ID: 12910348
    [Abstract] [Full Text] [Related]

  • 3. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics.
    Bender S, Grohmann R, Engel RR, Degner D, Dittmann-Balcar A, Rüther E.
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S46-53. PubMed ID: 15052514
    [Abstract] [Full Text] [Related]

  • 4. [Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics].
    Portier A, Sarfati Y.
    Encephale; 2000 Mar; 26(4):75-7. PubMed ID: 11064844
    [Abstract] [Full Text] [Related]

  • 5. [Neuroleptic treatment by the established psychiatrist. A report of experiences].
    Haberfellner EM, Rittmannsberger H.
    Psychiatr Prax; 1998 Nov; 25(6):284-5. PubMed ID: 9885840
    [Abstract] [Full Text] [Related]

  • 6. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C, Eser D, Schüle C, Zwanzger P, Marcuse A, Noack I, Möller HJ, Rupprecht R, Baghai TC.
    World J Biol Psychiatry; 2006 Nov; 7(3):162-70. PubMed ID: 16861142
    [Abstract] [Full Text] [Related]

  • 7. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT, Rada RT.
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [Abstract] [Full Text] [Related]

  • 8. [Principles of chemotherapy of paranoid schizophrenia].
    Vanelle JM, Loloum T.
    Encephale; 1991 May; 17(4):235-40. PubMed ID: 1683623
    [Abstract] [Full Text] [Related]

  • 9. [Clinical psychopathological research on late-onset schizophrenia--mainly patients with schizophrenia from a hospital psychiatric ward].
    Yasuda M, Kato S.
    Seishin Shinkeigaku Zasshi; 2009 May; 111(3):250-71. PubMed ID: 19425390
    [Abstract] [Full Text] [Related]

  • 10. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
    Novak Sarotar B, Pesek MB, Agius M, Kocmur M.
    Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
    [Abstract] [Full Text] [Related]

  • 11. Algorithm for treatment-refractory schizophrenia.
    Koshino Y.
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S9-13. PubMed ID: 10560891
    [Abstract] [Full Text] [Related]

  • 12. Social aspects of therapy with depot neuroleptics in the Federal Republic of Germany.
    Haring C, Tegeler J, Lehmann E, Ptock WD.
    Acta Psychiatr Belg; 1981 Oct; 81(2):189-202. PubMed ID: 6117189
    [Abstract] [Full Text] [Related]

  • 13. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
    Bobes J, Fillat O, Arango C.
    Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
    [Abstract] [Full Text] [Related]

  • 14. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P, Bret MC, Queuille E.
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [Abstract] [Full Text] [Related]

  • 15. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
    Beszłej JA, Grzesiak M.
    Psychiatr Pol; 2005 Apr; 39(2):293-307. PubMed ID: 15881624
    [Abstract] [Full Text] [Related]

  • 16. Atypical antipsychotic induced obsessive-compulsive symptoms.
    Teh EE, Najib MA.
    Med J Malaysia; 2004 Dec; 59(5):690-1. PubMed ID: 15889578
    [No Abstract] [Full Text] [Related]

  • 17. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M, Knopf U, Henn FA, Thome J.
    Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
    [Abstract] [Full Text] [Related]

  • 18. Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department.
    Sorensen L, Nielsen B, Stage KB, Brøsen K, Damkier P.
    Nord J Psychiatry; 2008 Jan; 62(3):242-9. PubMed ID: 18622885
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
    Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S.
    Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
    [Abstract] [Full Text] [Related]

  • 20. [The analysis of factors prior to positive symptoms relapse in schizophrenia].
    Melcer P, Rabe-Jabłońska J.
    Psychiatr Pol; 2002 Apr; 36(6 Suppl):271-81. PubMed ID: 12647449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.